logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Daniel E McCallus

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 17(Granted Patents)


Location History:

  • Oaks, PA (US) (2011 - 2013)
  • Cambridge, MA (US) (2015)

Company Filing History:

goldMedal4 out of 444 
 
Alnylam Pharmaceuticals, Inc.
 patents

Years Active: 2011-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents
1. 9198927 - Targeting opposite strand replication intermediates of single-stranded viruses by RNAI (2015-12-01),
2. 8987227 - Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use (2015-03-24),
3. 8614198 - Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use (2013-12-24),
4. 7985581 - Multiple RNA polymerase III promoter expression constructs (2011-07-26),
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…